- Home
- ALLO vs CDRO Comparison
ALLO vs CDRO Comparison
Compare ALLO & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- CDRO
- Stock Information
- Founded
- ALLO 2017
- CDRO 2014
- Country
- ALLO United States
- CDRO Luxembourg
- Employees
- ALLO N/A
- CDRO N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- CDRO Services-Misc. Amusement & Recreation
- Sector
- ALLO Health Care
- CDRO Consumer Discretionary
- Exchange
- ALLO Nasdaq
- CDRO Nasdaq
- Market Cap
- ALLO 371.8M
- CDRO 371.5M
- IPO Year
- ALLO 2018
- CDRO N/A
- Fundamental
- Price
- ALLO $1.11
- CDRO $7.30
- Analyst Decision
- ALLO Strong Buy
- CDRO Strong Buy
- Analyst Count
- ALLO 10
- CDRO 2
- Target Price
- ALLO $8.90
- CDRO $10.00
- AVG Volume (30 Days)
- ALLO 4.1M
- CDRO 26.7K
- Earning Date
- ALLO 05-13-2025
- CDRO 05-16-2025
- Dividend Yield
- ALLO N/A
- CDRO N/A
- EPS Growth
- ALLO N/A
- CDRO N/A
- EPS
- ALLO N/A
- CDRO N/A
- Revenue
- ALLO N/A
- CDRO $202,635,808.00
- Revenue This Year
- ALLO N/A
- CDRO $31.60
- Revenue Next Year
- ALLO $9.07
- CDRO $7.17
- P/E Ratio
- ALLO N/A
- CDRO N/A
- Revenue Growth
- ALLO N/A
- CDRO 35.94
- 52 Week Low
- ALLO $0.86
- CDRO $5.75
- 52 Week High
- ALLO $3.78
- CDRO $8.76
- Technical
- Relative Strength Index (RSI)
- ALLO 38.30
- CDRO 41.01
- Support Level
- ALLO $1.07
- CDRO $7.51
- Resistance Level
- ALLO $1.15
- CDRO $7.49
- Average True Range (ATR)
- ALLO 0.14
- CDRO 0.37
- MACD
- ALLO -0.01
- CDRO -0.08
- Stochastic Oscillator
- ALLO 27.17
- CDRO 20.63
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Italy, Mexico, Colombia, Panama, and the City of Buenos Aires, where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. If the user wins, it pays out the bet. If the user loses, it keeps the amount wagered.